What does CUSIP 00847L100 represent in this 13F holders report?

CUSIP 00847L100 is the security identifier for AGRX - AGILE THERAPEUTICS INC - COM used to aggregate holder disclosures.

How many institutions held AGRX - AGILE THERAPEUTICS INC - COM in Q2 2020?

80 institutional investors reported AGRX - AGILE THERAPEUTICS INC - COM for Q2 2020. Use the holders table for investor-level position and value details.

AGILE THERAPEUTICS INC - COM (AGRX)

CUSIP: 00847L100

Q2 2020 13F Holders as of 30 Jun 2020

Security type / class: Equity / COM
Total 13F shares: 38,477,855
Total 13F value: $106,962,531
Share change: +5,463,983
Put/Call ratio: 37%
SEC-reported price per share: $2.78
Number of holders: 80
Value change: +$17,293,150
Number of buys: 58
Number of sells: 23

Security key

00847L100

Report period

Q2 2020

Institutions

Top holders

AGRX full security history Ownership snapshot Full 13F holder table AGILE THERAPEUTICS INC SEC filings AGILE THERAPEUTICS INC company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of AGRX - AGILE THERAPEUTICS INC - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

PERCEPTIVE ADVISORS LLC

Disclosed value leader

PERCEPTIVE ADVISORS LLC

Comparable rows

0/15

Latest evidence

31 Mar 2020

13F Highest disclosed value: $29,611,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

PERCEPTIVE ADVISORS LLC has the largest disclosed position value at $29.61M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens PERCEPTIVE ADVISORS LLC's linked filing trail.

Disclosed position value Top 5

PERCEPTIVE ADVISORS LLC $29.61M

INVESTOR AB $6.53M

VANGUARD GROUP INC $6.34M

MILLENNIUM MANAGEMENT LLC $2.58M

BlackRock Finance, Inc. $2.34M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
PERCEPTIVE ADVISORS LLC	13F Company 13F	— denominator unverified	$29,611,000 15,919,325 shares	—	31 Mar 2020
INVESTOR AB	13F Company 13F	— denominator unverified	$6,529,000 3,510,189 shares	—	31 Mar 2020
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$6,337,000 3,406,889 shares	—	31 Mar 2020
MILLENNIUM MANAGEMENT LLC	13F Company 13F	— denominator unverified	$2,582,000 1,388,336 shares	—	31 Mar 2020
BlackRock Finance, Inc.	13F Company 13F	— denominator unverified	$2,341,000 1,258,808 shares	—	31 Mar 2020
ORBIMED ADVISORS LLC	13F Company 13F	— denominator unverified	$2,232,000 1,200,000 shares	—	31 Mar 2020

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

38,477,855

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders

Q2 2020 holders

Holder diff

Investor	Q1 2020 Shares	Q2 2020 Shares	Share Diff	Share Chg %	Q1 2020 value	Q2 2020 value	Value change	Value Chg %